ArticleJournal of the American Chemical Society2019

Chemical Synthesis Enables Structural Reengineering of Aglaroxin C Leading to Inhibition Bias for Hepatitis C Viral Infection.

Wenhan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.